Medlive Technology Co., Ltd.

SEHK:2192 Stock Report

Market Cap: HK$6.2b

Medlive Technology Past Earnings Performance

Past criteria checks 4/6

Medlive Technology has been growing earnings at an average annual rate of 47.3%, while the Healthcare Services industry saw earnings growing at 13.8% annually. Revenues have been growing at an average rate of 20.9% per year. Medlive Technology's return on equity is 6.4%, and it has net margins of 60.2%.

Key information

47.3%

Earnings growth rate

39.8%

EPS growth rate

Healthcare Services Industry Growth22.3%
Revenue growth rate20.9%
Return on equity6.4%
Net Margin60.2%
Last Earnings Update30 Jun 2024

Recent past performance updates

Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings

Oct 02
Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings

Recent updates

Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings

Oct 02
Investors Shouldn't Be Too Comfortable With Medlive Technology's (HKG:2192) Earnings

Pinning Down Medlive Technology Co., Ltd.'s (HKG:2192) P/E Is Difficult Right Now

Sep 27
Pinning Down Medlive Technology Co., Ltd.'s (HKG:2192) P/E Is Difficult Right Now

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 04
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Apr 08
Medlive Technology Co., Ltd.'s (HKG:2192) Business Is Yet to Catch Up With Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Feb 20
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Jan 10
Are Medlive Technology Co., Ltd. (HKG:2192) Investors Paying Above The Intrinsic Value?

Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Sep 27
Medlive Technology Co., Ltd.'s (HKG:2192) Intrinsic Value Is Potentially 20% Below Its Share Price

Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Jul 10
Medlive Technology (HKG:2192) Is Reinvesting At Lower Rates Of Return

Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

May 11
Medlive Technology Co., Ltd. (HKG:2192) Shares Slammed 28% But Getting In Cheap Might Be Difficult Regardless

Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

May 02
Robust Earnings May Not Tell The Whole Story For Medlive Technology (HKG:2192)

Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Mar 26
Results: Medlive Technology Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

Feb 06
Here's What's Concerning About Medlive Technology's (HKG:2192) Returns On Capital

There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Oct 31
There Are Reasons To Feel Uneasy About Medlive Technology's (HKG:2192) Returns On Capital

Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

Jul 14
Medlive Technology (HKG:2192) Could Be Struggling To Allocate Capital

These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Apr 03
These Analysts Just Made A Massive Downgrade To Their Medlive Technology Co., Ltd. (HKG:2192) EPS Forecasts

Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Feb 22
Is Medlive Technology Co., Ltd. (HKG:2192) Worth HK$9.5 Based On Its Intrinsic Value?

Revenue & Expenses Breakdown

How Medlive Technology makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SEHK:2192 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244822901960
31 Mar 244472661870
31 Dec 234122421770
30 Sep 233842161670
30 Jun 233561891580
31 Mar 233351531550
31 Dec 223141171510
30 Sep 22300831430
30 Jun 22286481350
31 Mar 22285441310
31 Dec 21284411280
30 Sep 21270551090
30 Jun 2125570890
31 Mar 2123478710
31 Dec 2021485530
31 Dec 1912231370
31 Dec 188314310

Quality Earnings: 2192 has a high level of non-cash earnings.

Growing Profit Margin: 2192's current net profit margins (60.2%) are higher than last year (53.2%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 2192's earnings have grown significantly by 47.3% per year over the past 5 years.

Accelerating Growth: 2192's earnings growth over the past year (53.5%) exceeds its 5-year average (47.3% per year).

Earnings vs Industry: 2192 earnings growth over the past year (53.5%) exceeded the Healthcare Services industry 11.1%.


Return on Equity

High ROE: 2192's Return on Equity (6.4%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies